OR WAIT null SECS
Mark Rogers, PhD, mark.rogers@sgs.com, is the global scientific director for the SGS Health Science Drug Development group.
August 02, 2021
Establishing extractable and leachable studies for complex biotherapeutic molecules poses new challenges for analytical assessment.
New challenges arise in extractable and leachable studies for cell and gene therapy products.